A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways
Ying Liu(Hubei University of Medicine), Shipeng He(Shanghai University)
Cited by 37
Related Papers
The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer
|Acta Materia Medica|2022|15